Reading Room Production — page 252

AID) [--] > let us know if you are able to 2rtain aspects were fficial to sign off on 4/27/20. you understand, since this is a sensitive I'm happy to discuss further if you have From: Linde, Emily (NIH/NIAID) [E] @mail.nih.gov> Sent: Thursday, May 21, 2020 6:17 AM To: Sanders, Ashley (NIH/OD) [E] @nih.gov> Cc: Shannon, Mike (NIH/OD) [E] @nih.gov>; Stemmy, Erik (NIH/NIAID) [E] @nih.gov> Subject: RE: Grant Questions - FBI Inquiry - 1-R01AI110964-01 - 2-R01AI110964-06 Hi Ashley, The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily From: Sanders, Ashley (NIH/OD) [E] @nih.gov> Sent: Wednesday, May 20, 2020 1:00 PM To: Linde, Emily (NIH/NIAID) [E] @mail.nih.gov> Cc: Shannon, Mike (NIH/OD) [E] @nih.gov> Subject: RE: Grant Questions - FBI Inquiry - 1-R01AI110964-01 - 2-R01AI110964-06 Importance: High Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley From: Sanders, Ashley (NIH/OD) [E] Sent: Wednesday, May 13, 2020 11:59 AM To: Linde, Emily (NIH/NIAID) [E] @mail.nih.gov> Cc: Shannon, Mike (NIH/OD) [E] @nih.gov> Subject: Grant Questions - FBI Inquiry - 1-R01AI110964-01 - 2-R01AI110964-06 Importance: High Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our office and the agent? If not, who would be the best SME on this matter? I'm sure you understand, since this is a sensitive matter, we need to maintain confidentiality and limit the touch-points within NIH. I'm happy to discuss further if you have any questions. Thank you, Ashley